Literature DB >> 27025682

Phospholipase A2 Receptor Gene Polymorphisms Alter its Functions and Present a Genetic Risk of an Increased Intima-Media Thickness of the Carotid Artery.

Nguyen Van Si1, Daisuke Fujioka, Kazuhiro Watanabe, Yosuke Watanabe, Kazunori Watanabe, Kazuto Nakamura, Kazuyuki Yamaguchi, Manabu Uematsu, Kiyotaka Kugiyama.   

Abstract

AIMS: Phospholipase A2 receptor 1 (PLA2R) has multiple biological functions other than functioning as a receptor for secretory PLA2s. Two nonsynonymous polymorphisms in the C-type lectin-like domains (CTLD) 1 of PLA2R gene have been associated with idiopathic membranous nephropathy. This study examined whether the same PLA2R polymorphisms may alter functions of PLA2R in cells expressing the variant PLA2R. In addition, the clinical relevance of the experiment was examined.
METHODS: Two nonsynonymous polymorphisms (T/C at rs3749117 and G/C at rs35771982) in CTLD1 of PLA2R gene were completely linked. HEK293 cells expressing human wild-type PLA2R (T at rs3749117 and G at rs35771982) or human mutant PLA2R that had double mutations (C at rs3749117 and C at rs35771982) were constructed.
RESULTS: HEK293 cells expressing mutant PLA2R had lower migratory and proliferative responses to collagen I compared with cells expressing wild-type PLA2R. In 580 male patients, PLA2R gene polymorphisms were associated with an increase in maximum intima-media thickness (maxIMT) of the carotid artery. The multivariate regression model showed that PLA2R gene polymorphisms were a risk factor of an increased maxIMT that was independent of conventional risk factors (OR=1.93, 95% CI: 1.17-3.19, p<0.01).
CONCLUSIONS: The nonsynonymous common variants of PLA2R gene altered biological functions in cells expressing variant PLA2R. PLA2R gene polymorphisms present a genetic risk of an increased IMT of the carotid artery in male. The functional changes in the variant PLA2R may potentially be responsible for its association with an increased IMT of the carotid artery.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27025682      PMCID: PMC5098923          DOI: 10.5551/jat.34330

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  28 in total

1.  C-type lectin-like domain and fibronectin-like type II domain of phospholipase A(2) receptor 1 modulate binding and migratory responses to collagen.

Authors:  Soichiro Takahashi; Kazuhiro Watanabe; Yosuke Watanabe; Daisuke Fujioka; Takamitsu Nakamura; Kazuto Nakamura; Jun-ei Obata; Kiyotaka Kugiyama
Journal:  FEBS Lett       Date:  2015-02-25       Impact factor: 4.124

2.  Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor.

Authors:  Morgane Rouault; Catherine Le Calvez; Eric Boilard; Fanny Surrel; Alan Singer; Farideh Ghomashchi; Sofiane Bezzine; Sabine Scarzello; James Bollinger; Michael H Gelb; Gérard Lambeau
Journal:  Biochemistry       Date:  2007-02-13       Impact factor: 3.162

Review 3.  Endothelial function and dysfunction: testing and clinical relevance.

Authors:  John E Deanfield; Julian P Halcox; Ton J Rabelink
Journal:  Circulation       Date:  2007-03-13       Impact factor: 29.690

4.  Echolucent Carotid Plaque is Associated with Future Renal Dysfunction in Patients with Stable Coronary Artery Disease.

Authors:  Tetsuji Mochida; Takamitsu Nakamura; Kazuto Nakamura; Daisuke Fujioka; Yukio Saito; Jun-Ei Obata; Yosuke Watanabe; Kazuhiro Watanabe; Kiyotaka Kugiyama
Journal:  J Atheroscler Thromb       Date:  2014-12-27       Impact factor: 4.928

5.  Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.

Authors:  Horia C Stanescu; Mauricio Arcos-Burgos; Alan Medlar; Detlef Bockenhauer; Anna Kottgen; Liviu Dragomirescu; Catalin Voinescu; Naina Patel; Kerra Pearce; Mike Hubank; Henry A F Stephens; Valerie Laundy; Sandosh Padmanabhan; Anna Zawadzka; Julia M Hofstra; Marieke J H Coenen; Martin den Heijer; Lambertus A L M Kiemeney; Delphine Bacq-Daian; Benedicte Stengel; Stephen H Powis; Paul Brenchley; John Feehally; Andrew J Rees; Hanna Debiec; Jack F M Wetzels; Pierre Ronco; Peter W Mathieson; Robert Kleta
Journal:  N Engl J Med       Date:  2011-02-17       Impact factor: 91.245

6.  Cloning and expression of a membrane receptor for secretory phospholipases A2.

Authors:  G Lambeau; P Ancian; J Barhanin; M Lazdunski
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

7.  The mannose receptor family.

Authors:  Lucy East; Clare M Isacke
Journal:  Biochim Biophys Acta       Date:  2002-09-19

8.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

9.  Deficiency of phospholipase A2 receptor exacerbates ovalbumin-induced lung inflammation.

Authors:  Shun Tamaru; Hideto Mishina; Yosuke Watanabe; Kazuhiro Watanabe; Daisuke Fujioka; Soichiro Takahashi; Koji Suzuki; Takamitsu Nakamura; Jun-Ei Obata; Kenichi Kawabata; Yasunori Yokota; Makoto Murakami; Kohji Hanasaki; Kiyotaka Kugiyama
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

10.  Lack of phospholipase A2 receptor increases susceptibility to cardiac rupture after myocardial infarction.

Authors:  Hideto Mishina; Kazuhiro Watanabe; Shun Tamaru; Yosuke Watanabe; Daisuke Fujioka; Soichiro Takahashi; Koji Suzuki; Takamitsu Nakamura; Jun-Ei Obata; Kenichi Kawabata; Yasunori Yokota; Osamu Inoue; Makoto Murakami; Kohji Hanasaki; Kiyotaka Kugiyama
Journal:  Circ Res       Date:  2013-12-04       Impact factor: 17.367

View more
  2 in total

1.  Genetic susceptibility to cerebrovascular disease: A systematic review.

Authors:  Christoph J Griessenauer; Sean Farrell; Atom Sarkar; Ramin Zand; Vida Abedi; Neil Holland; Andrew Michael; Christopher L Cummings; Raghu Metpally; David J Carey; Oded Goren; Neil Martin; Philipp Hendrix; Clemens M Schirmer
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-05       Impact factor: 6.200

2.  Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy.

Authors:  Amanda P Waller; Jonathan P Troost; Samir V Parikh; Katelyn J Wolfgang; Brad H Rovin; Marvin T Nieman; William E Smoyer; Matthias Kretzler; Bryce A Kerlin
Journal:  Thromb Res       Date:  2021-02-16       Impact factor: 3.944

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.